We are a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer.

Click on the link below for our latest corporate presentation.

Clinical Trials Information

Resources and guides for patients and caregivers.

Click on the link below for more information.

Latest News

MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
Read More

MacroGenics to Participate in Upcoming Investor Conferences
Read More

Please note – you will leave a website owned by MacroGenics, Inc.

MacroGenics is not responsible for any content on the third party website.

Ok Close